The Pneumatic Retinopexy versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomized Trial (PIVOT).


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
04 2019
Historique:
received: 27 08 2018
revised: 22 10 2018
accepted: 06 11 2018
pubmed: 24 11 2018
medline: 4 1 2020
entrez: 24 11 2018
Statut: ppublish

Résumé

The optimal surgery to repair rhegmatogenous retinal detachment (RRD) is unknown. The purpose of this trial was to compare outcomes of pneumatic retinopexy (PnR) versus pars plana vitrectomy (PPV) for the management of primary RRD. Prospective, randomized controlled trial. Patients with RRD demonstrating a single retinal break or a group of breaks in detached retina within 1 clock hour above the 8- and 4-o'clock meridians, with any number, location and size of retinal breaks or lattice degeneration in attached retina. Patients were randomized to undergo either PnR or PPV. Macula-on and macula-off patients were assigned to intervention group by stratified randomization and were treated within 24 and 72 hours, respectively. The primary outcome was 1-year Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity (VA). Important secondary outcomes were subjective visual function (25-item National Eye Institute Visual Function Questionnaire), metamorphopsia score (M-CHARTS), and primary anatomic success. One hundred seventy-six patients were recruited between August 2012 and May 2016. ETDRS VA after PnR exceeded that after PPV by 4.9 letters at 12 months (79.9±10.4 letters vs. 75.0±15.2 letters; P = 0.024). Mean ETDRS VA also was superior for the PnR group compared with the PPV group at 3 months (78.4±12.3 letters vs. 68.5±17.8 letters) and 6 months (79.2±11.1 letters vs. 68.6±17.2 letters). Composite 25-item National Eye Institute Visual Function Questionnaire scores were superior for PnR at 3 and 6 months. Vertical metamorphopsia scores were superior for the PnR group compared with the PPV group at 12 months (0.14±0.29 vs. 0.28±0.42; P = 0.026). Primary anatomic success at 12 months was achieved by 80.8% of patients undergoing PnR versus 93.2% undergoing PPV (P = 0.045), with 98.7% and 98.6%, respectively, achieving secondary anatomic success. Sixty-five percent of phakic patients in the PPV arm underwent cataract surgery in the study eye before 12 months versus 16% in the PnR group (P < 0.001). Pneumatic retinopexy should be considered the first line treatment for RRD in patients fulfilling Pneumatic Retinopexy versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomized Trial (PIVOT) recruitment criteria. Pneumatic retinopexy offers superior VA, less vertical metamorphopsia, and reduced morbidity when compared with PPV.

Identifiants

pubmed: 30468761
pii: S0161-6420(18)32275-9
doi: 10.1016/j.ophtha.2018.11.014
pii:
doi:

Substances chimiques

Fluorocarbons 0
perflutren CK0N3WH0SR
Sulfur Hexafluoride WS7LR3I1D6

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

531-539

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2018 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Roxane J Hillier (RJ)

Department of Ophthalmology, St. Michael's Hospital, Toronto, Canada; Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Canada; Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom; Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom. Electronic address: roxanehillier@gmail.com.

Tina Felfeli (T)

Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Canada.

Alan R Berger (AR)

Department of Ophthalmology, St. Michael's Hospital, Toronto, Canada; Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Canada.

David T Wong (DT)

Department of Ophthalmology, St. Michael's Hospital, Toronto, Canada; Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Canada.

Filiberto Altomare (F)

Department of Ophthalmology, St. Michael's Hospital, Toronto, Canada; Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Canada.

David Dai (D)

Applied Health Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.

Louis R Giavedoni (LR)

Department of Ophthalmology, St. Michael's Hospital, Toronto, Canada; Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Canada.

Peter J Kertes (PJ)

Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Canada; Kensington Vision and Research Center, Toronto, Canada; The John and Liz Tory Eye Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.

Radha P Kohly (RP)

Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Canada; Kensington Vision and Research Center, Toronto, Canada; The John and Liz Tory Eye Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.

Rajeev H Muni (RH)

Department of Ophthalmology, St. Michael's Hospital, Toronto, Canada; Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Canada; Kensington Vision and Research Center, Toronto, Canada. Electronic address: rajeev.muni@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH